APOKYN Side Effects

7018673-6 | Angina Pectoris, Dizziness, Headache, Influenza Like Illness, Malaise, Pyrexia
on Sep 07, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, dizziness (What is dizziness?), headache (What is headache?), influenza like illness, malaise, pyrexia. Apokyn dosage: (0.4 Ml),parenteral.

6968769-X | Abasia, Mobility Decreased, Muscle Spasms, Musculoskeletal Stiffness, Pain, Sudden Onset Of Sleep
Patient was taking Apokyn (View Usage). Patient had the following side effects: abasia, mobility decreased, muscle spasms, musculoskeletal stiffness, pain (What is pain?), sudden onset of sleep on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 3 Mg, As Required/reduced. During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), REQUIP XL (16 Mg (4 Mg, Oral), 20 Mg (4 Mg), Oral/increased) (View Requip Xl Review and Requip Xl Label ), SINEMET (See Image, Increased) (View Sinemet Review and Sinemet Label ), COMTAN (800 Mg (200 Mg, 4 In 1 D), 1000 Mg (200 Mg, 5 In 1 D) Increased) (View Comtan Review and Comtan Label ).

6966209-8 | Therapeutic Response Delayed, Urinary Tract Infection
Adverse event was reported on Aug 19, 2010 by a Male patient taking Apokyn (View Usage) (Dosage: 1.6 To 2.0 Ml/day (0.4 Ml, 4 To 5 Times A Day) Subcutaneous) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 69 years of age, weighting 176.4 lb, After Apokyn was administered, patient had the following side effects: therapeutic response delayed, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with STALEVO (STALEVO) (View Stalevo (stalevo) Review and Stalevo (stalevo) Label ), ZELAPAR (SELEGILINE HYDROCHLORIDE) (View Zelapar (selegiline Hydrochloride) Review and Zelapar (selegiline Hydrochloride) Label ), REQUIP (View Requip Review and Requip Label ). Patient was hospitalized.

6843060-0 | Abasia, Immobile, Insomnia, Muscle Spasms, Musculoskeletal Stiffness, Pain, Somnolence
on Jun 29, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, immobile, insomnia, muscle spasms, musculoskeletal stiffness, pain (What is pain?), somnolence. Apokyn dosage: 3 Ml 0 To 4 Times Per Day (3 Ml, As Required),. During the same period patient was treated with REQUIP XL (20 Mg (4 Mg,), Oral) (View Requip Xl Review and Requip Xl Label ), SINEMET (4 Dosage Forms (1 Dosage Forms, 4 In 1 D), Oral) (View Sinemet Review and Sinemet Label ), COMTAN (800 Mg (200 Mg, 4 In 1 D),) (View Comtan Review and Comtan Label ).


6812890-3 | Haemorrhage
on Jun 17, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: haemorrhage. Apokyn dosage: (0.2 Ml), Subcutaneous. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), COMTAN (View Comtan Review and Comtan Label ), SINEMET (View Sinemet Review and Sinemet Label ), MIRAPEX (View Mirapex Review and Mirapex Label ).

6812879-4 | Pneumonia
Patient was taking Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Jun 21, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: (0.3 Mg, Four Times A Day As Required). Patient was hospitalized.

6799590-3 | Aspiration, Dysphagia
Adverse event was reported on Jun 14, 2010 by a Male patient taking Apokyn (View Usage) (Dosage: (0.4 Ml, 3-4 Times Daily/as Required); (0.2 Ml, As Required);) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: aspiration, dysphagia. During the same period patient was treated with LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), QUALAQUIN (QUININE) (View Qualaquin (quinine) Review and Qualaquin (quinine) Label ), TRICOR (View Tricor Review and Tricor Label ), PLAVIX (View Plavix Review and Plavix Label ), STALEVO (STALEVO) (View Stalevo (stalevo) Review and Stalevo (stalevo) Label ), ZELAPAR (SELEGILINE HYDROCHLORIDE) (View Zelapar (selegiline Hydrochloride) Review and Zelapar (selegiline Hydrochloride) Label ), FLONASE (View Flonase Review and Flonase Label ), NITROQUICK (GLYCERYL TRINITRATE) (View Nitroquick (glyceryl Trinitrate) Review and Nitroquick (glyceryl Trinitrate) Label ).

6799507-1 | Pulmonary Thrombosis
on Jun 10, 2010 Male patient from UNITED STATES , 71 years of age, weighting 147.7 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: pulmonary thrombosis. Apokyn dosage: (0.3 Mg, Up To 5 Times), Subcutaneous. During the same period patient was treated with STALEVO (STALEVO) (View Stalevo (stalevo) Review and Stalevo (stalevo) Label ), HUMULIN (INSULIN HUMAN) (View Humulin (insulin Human) Review and Humulin (insulin Human) Label ), AMARYL (View Amaryl Review and Amaryl Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ), KLOR CON (View Klor-con Review and Klor-con Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), RAZADYNE (View Razadyne Review and Razadyne Label ).

6782500-2 |
on Jun 09, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). . Apokyn dosage: 0.3 Ml.

6763742-9 | Blood Pressure Decreased, Depressed Level Of Consciousness, Fall, Hallucination, Somnolence
Patient was taking Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, depressed level of consciousness, fall (What is fall?), hallucination, somnolence on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.2 Mg; Subcutaneous; 0.4 Mg; Subcutaneous. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), SINEMET (View Sinemet Review and Sinemet Label ), VESICARE (View Vesicare Review and Vesicare Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GALANTAMINE (GALANTAMINE) (View Galantamine (galantamine) Review and Galantamine (galantamine) Label ).

6753681-1 | Inguinal Hernia
Adverse event was reported on Apr 28, 2008 by a Male patient taking Apokyn (View Usage) (Dosage: 0.3 Ml 1 To 5 Times Daily (0.3 Ml, 1 To 5 Times Daily), Subcutaneous) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 79 years of age, Patient had the following side effects: inguinal hernia. During the same period patient was treated with MOBIC (View Mobic Review and Mobic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ARICEPT (View Aricept Review and Aricept Label ), TASMAR (TOLCAPONE) (TOLCAPONE) (View Tasmar (tolcapone) (tolcapone) Review and Tasmar (tolcapone) (tolcapone) Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE) (DESMOPRESSIN ACETATE) (View Desmopressin Acetate (desmopressin Acetate) (desmopressin Acetate) Review and Desmopressin Acetate (desmopressin Acetate) (desmopressin Acetate) Label ), GLUCOSAMINE W/CHONDROITIN (GLUCOSAMINE W/CHONDROITIN) (CHONDROITIN SUL (View Glucosamine W/chondroitin (glucosamine W/chondroitin) (chondroitin Sul Review and Glucosamine W/chondroitin (glucosamine W/chondroitin) (chondroitin Sul Label ), DOCUSATE CALCIUM (DOCUSATE CALCIUM) (DOCUSATE CALCIUM) (View Docusate Calcium (docusate Calcium) (docusate Calcium) Review and Docusate Calcium (docusate Calcium) (docusate Calcium) Label ).

6724701-5 | Myocardial Infarction
on Apr 28, 2010 Female patient from UNITED STATES , 55 years of age, weighting 299.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: myocardial infarction. Apokyn dosage: Subcutaneous. During the same period patient was treated with CARBIDOPA LEVODOPA (View Carbidopa-levodopa Review and Carbidopa-levodopa Label ), COMTAN (View Comtan Review and Comtan Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), VENLAXAFINE (VENLAFAXINE) (View Venlaxafine (venlafaxine) Review and Venlaxafine (venlafaxine) Label ), SELEGINE (SELEGILINE HYDROCHLORIDE) (View Selegine (selegiline Hydrochloride) Review and Selegine (selegiline Hydrochloride) Label ), ACCUPRIL (View Accupril Review and Accupril Label ), BROMOCRIPTINE (View Bromocriptine Review and Bromocriptine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6718502-1 | Disease Progression, Fall, Parkinson's Disease, Weight Decreased
on Apr 27, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, fall (What is fall?), parkinson's disease (What is parkinson's disease?), weight decreased. Apokyn dosage: 0.3 Ml, As Required 2 To 3 Times Per Day, Parenteral. During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), MEGACE (View Megace Review and Megace Label ), EXELON (View Exelon Review and Exelon Label ), NAMENDA (View Namenda Review and Namenda Label ), REQUIP (View Requip Review and Requip Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), ZELAPAR (SELEGILINE HYDROCHLORIDE) (View Zelapar (selegiline Hydrochloride) Review and Zelapar (selegiline Hydrochloride) Label ), ARTHROTEC (View Arthrotec Review and Arthrotec Label ).

6718311-3 | Activities Of Daily Living Impaired, Condition Aggravated, Lethargy, Movement Disorder, Nephrolithiasis, Parkinson's Disease, Posture Abnormal, Somnolence, Ventricular Extrasystoles
Patient was taking Apokyn (View Usage). Patient had the following side effects: activities of daily living impaired, condition aggravated, lethargy, movement disorder (What is movement disorder?), nephrolithiasis, parkinson's disease (What is parkinson's disease?), posture abnormal, somnolence, ventricular extrasystoles on Sep 05, 2007 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: See Image. During the same period patient was treated with TRAZODONE (TRAZODONE) (TRAZODONE) (View Trazodone (trazodone) (trazodone) Review and Trazodone (trazodone) (trazodone) Label ). Patient was hospitalized and became disabled.

6707071-8 | Confusional State, Pneumonia
Adverse event was reported on Apr 16, 2010 by a Male patient taking Apokyn (View Usage) (Dosage: 0.2 Ml Given 1-3 Times/day (0.2 Ml, 1-3 Times/day)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 67 years of age, weighting 189.6 lb, After Apokyn was administered, patient had the following side effects: confusional state, pneumonia (What is pneumonia?). During the same period patient was treated with TIGAN (View Tigan Review and Tigan Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), EXELON (View Exelon Review and Exelon Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ). Patient was hospitalized.

6701550-5 | Musculoskeletal Disorder
on Apr 12, 2010 Male patient from UNITED STATES , 66 years of age, weighting 190.5 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: musculoskeletal disorder. Apokyn dosage: 0.2 Ml, 1-3 Tiimes A Day. During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), TIGAN (View Tigan Review and Tigan Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6636468-X | Cerebrovascular Accident, Somnolence
on Nov 06, 2006 Male patient from UNITED STATES , 70 years of age, weighting 198.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: cerebrovascular accident, somnolence. Apokyn dosage: (0.2 Ml), Subcutaneous, (0.1 Ml), Subcutaneous. During the same period patient was treated with SINEMET (SINEMET) (CARBIDOPA, LEVODOPA) (View Sinemet (sinemet) (carbidopa, Levodopa) Review and Sinemet (sinemet) (carbidopa, Levodopa) Label ), PERMAX (PERGOLIDE MESLATE) (PERGOLIDE MESILATE) (View Permax (pergolide Meslate) (pergolide Mesilate) Review and Permax (pergolide Meslate) (pergolide Mesilate) Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), DETROPAN (OXYBUTYNIN) (OXYBUTYNIN) (View Detropan (oxybutynin) (oxybutynin) Review and Detropan (oxybutynin) (oxybutynin) Label ), IRON (IRON) (IRON) (View Iron (iron) (iron) Review and Iron (iron) (iron) Label ), NAMENDA (MEMANTINE HYDROCHLORIDE) (MEMANTINE HYDROCHOLORIDE) (View Namenda (memantine Hydrochloride) (memantine Hydrocholoride) Review and Namenda (memantine Hydrochloride) (memantine Hydrocholoride) Label ), PLAVIX (CLOPIDOGREL SULFATE) (CLOPIDOGREL) (View Plavix (clopidogrel Sulfate) (clopidogrel) Review and Plavix (clopidogrel Sulfate) (clopidogrel) Label ).

6618503-8 | Dizziness, Dyskinesia, Fall, Headache, Hyperhidrosis, Lower Limb Fracture
Patient was taking Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: dizziness (What is dizziness?), dyskinesia, fall (What is fall?), headache (What is headache?), hyperhidrosis, lower limb fracture on May 17, 2007 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: (0.4 Ml), Subcutaneous. During the same period patient was treated with AZILECT (RASAGILINE MESYLATE) (RASAGILINE MESYLATE) (View Azilect (rasagiline Mesylate) (rasagiline Mesylate) Review and Azilect (rasagiline Mesylate) (rasagiline Mesylate) Label ), SINEMET 25/100 (SINEMET) (CARBIDOPA, LEVODOPA) (View Sinemet 25/100 (sinemet) (carbidopa, Levodopa) Review and Sinemet 25/100 (sinemet) (carbidopa, Levodopa) Label ), MIRAPEX (PRAMIPEXOLE DIHYDROCHLORIDE) (PRAMIPEXOLE DIHYDROCHLORIDE) (View Mirapex (pramipexole Dihydrochloride) (pramipexole Dihydrochloride) Review and Mirapex (pramipexole Dihydrochloride) (pramipexole Dihydrochloride) Label ). Patient was hospitalized.

6617003-9 | Dyskinesia, Hallucination, Off Label Use, Spontaneous Penile Erection
Adverse event was reported on Mar 10, 2009 by a Male patient taking Apokyn (View Usage) (Dosage: See Image) was diagnosed with depressed level of consciousness and. Location: ARGENTINA , 25 years of age, Patient experienced the following unwanted or unexpected effects: dyskinesia, hallucination, off label use, spontaneous penile erection.

6609167-8 | Contusion, Fall
on Apr 27, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: contusion, fall (What is fall?). Apokyn dosage: See Image. Patient was hospitalized.

6607047-5 | Dementia
on Jun 19, 2008 Male patient from UNITED STATES , 76 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: dementia (What is dementia?). Apokyn dosage: (0.3 Mg, As Required), Subcutaneous.

6602912-7 | Cerebrovascular Accident, Dyskinesia
Patient was taking Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, dyskinesia on May 16, 2007 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 103.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.2 Ml, Varied Frequency, Subcutaneous. During the same period patient was treated with STALEVO (STALEVO) (View Stalevo (stalevo) Review and Stalevo (stalevo) Label ), REQUIP (View Requip Review and Requip Label ), ELAVIL (View Elavil Review and Elavil Label ), LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), ARICEPT (View Aricept Review and Aricept Label ), PREMARIN (View Premarin Review and Premarin Label ), AMBIEN (View Ambien Review and Ambien Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6589792-3 | Nephrolithiasis
Adverse event was reported on Feb 02, 2010 by a Male patient taking Apokyn (View Usage) (Dosage: 0.24 Ml (0.6 Ml,4 In 1 D), Parenteral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 87 years of age, weighting 130.1 lb, Patient had the following side effects: nephrolithiasis. Patient was hospitalized.

6415059-X | Cardio-respiratory Arrest, Cellulitis, Erythema, Excoriation, Hiatus Hernia, Hilar Lymphadenopathy, Infection, Pneumonia Aspiration, Rash
on Oct 14, 2009 Male patient from UNITED STATES , 85 years of age, weighting 150.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: cardio-respiratory arrest, cellulitis (What is cellulitis?), erythema, excoriation, hiatus hernia, hilar lymphadenopathy, infection (What is infection?), pneumonia aspiration, rash (What is rash?). Apokyn dosage: 0.4ml Four Times Per Day (0.4 Ml, As Required), Subcutaneous. Patient was hospitalized and became disabled.

6411518-4 | Anxiety, Condition Aggravated, Fatigue, Feeling Abnormal, Headache, Nausea, Pharyngeal Oedema, Skin Tightness, Somnolence
on Oct 05, 2009 Female patient from UNITED STATES , 81 years of age, weighting 162.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), condition aggravated, fatigue, feeling abnormal, headache (What is headache?), nausea (What is nausea?), pharyngeal oedema, skin tightness, somnolence. Apokyn dosage: 0.8 Ml (0.2 Ml, 4 In 1 D), Subcutaneous. During the same period patient was treated with TIGAN (TRIMETHOBENZAMIDE HYDROCHLORIDE) (TRIMETHOBENZAMIDE HYDROCHLORI (View Tigan (trimethobenzamide Hydrochloride) (trimethobenzamide Hydrochlori Review and Tigan (trimethobenzamide Hydrochloride) (trimethobenzamide Hydrochlori Label ).

6334477-1 | Heart Rate Decreased, Hyperhidrosis, Hypotension, Nausea
Patient was taking Apokyn (View Usage). Patient had the following side effects: heart rate decreased, hyperhidrosis, hypotension, nausea (What is nausea?) on Aug 20, 2009 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: (0.2 Ml 1x Subcutaneous).

6305680-1 | Aggression, Blood Urine Present, Cold Sweat, Pallor
Adverse event was reported on Jul 31, 2009 by a Male patient taking Apokyn (View Usage) (Dosage: (0.2 Ml, Once To Twice Per Day Subcutaneous)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , weighting 223.0 lb, After Apokyn was administered, patient had the following side effects: aggression, blood urine present, cold sweat, pallor. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BUSPAR (View Buspar Review and Buspar Label ), SINEMET (View Sinemet Review and Sinemet Label ), COMTAN (View Comtan Review and Comtan Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LYRICA (View Lyrica Review and Lyrica Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

6285674-5 | Loss Of Consciousness, Nausea, Pallor, Respiratory Rate Decreased
on Jul 17, 2009 Male patient from UNITED STATES , weighting 163.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, nausea (What is nausea?), pallor, respiratory rate decreased. Apokyn dosage: (0.2 Ml Prn Subcutaneous). During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), AZILECT /01759902/ (View Azilect /01759902/ Review and Azilect /01759902/ Label ), CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), TIGAN (View Tigan Review and Tigan Label ), IMITREX /01044801/ (View Imitrex /01044801/ Review and Imitrex /01044801/ Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ).

6284494-5 | Cardiac Disorder, Cough, Dyspnoea, Gastrooesophageal Reflux Disease, Increased Bronchial Secretion
on Jul 16, 2009 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: cardiac disorder, cough, dyspnoea, gastrooesophageal reflux disease, increased bronchial secretion. Apokyn dosage: 0.4 Ml Qd Subcutaneous. During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), REMERON (View Remeron Review and Remeron Label ), PAXIL (View Paxil Review and Paxil Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

6245797-3 | No Therapeutic Response
Patient was taking Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: no therapeutic response on Jun 17, 2009 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: (0.4 Ml, 1 To 2 Times Per Day Subcutaneous).

6243962-2 | Cardiac Disorder, Cough, Dyspnoea, Increased Upper Airway Secretion
Adverse event was reported on Jun 15, 2009 by a Female patient taking Apokyn (View Usage) (Dosage: 0.4 Ml Qd Subcutaneous) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: cardiac disorder, cough, dyspnoea, increased upper airway secretion. During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), REMERON (View Remeron Review and Remeron Label ), PAXIL (View Paxil Review and Paxil Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

6243950-6 | Blood Pressure Fluctuation, Hypotension, Transient Ischaemic Attack
on Jun 15, 2009 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: blood pressure fluctuation, hypotension, transient ischaemic attack. Apokyn dosage: Df Subcutaneous 0.4 Ml Prn Subcutaneous 0.4 Ml Qd Subcutaneous. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ).

6237590-2 | Nausea, Swelling Face
on Jun 10, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), nausea (What is nausea?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: nausea (What is nausea?), swelling face. Apokyn dosage: 0.4 Ml, Subcutaneous. During the same period patient was treated with TIGAN (1 Df Tid, Oral) (View Tigan Review and Tigan Label ).

6229680-5 | Loss Of Consciousness, Sleep Attacks
Patient was taking Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, sleep attacks on Aug 05, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.2 Ml, Up To 5 Times A Day Subcutaneous. During the same period patient was treated with MIRAPEX (4 Mg Qd Oral) (View Mirapex Review and Mirapex Label ), SINEMET (1 Df Tid, 25/100 Oral) (View Sinemet Review and Sinemet Label ), SINEMET CR (2 Df, 50/200 Oral) (View Sinemet Cr Review and Sinemet Cr Label ), TIGAN (View Tigan Review and Tigan Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

6210658-2 | Cough, Dyspnoea, Increased Upper Airway Secretion
Adverse event was reported on May 19, 2009 by a Female patient taking Apokyn (View Usage) (Dosage: 0.4 Ml Qd Subcutaneous) . Location: UNITED STATES , weighting 205.0 lb, Patient had the following side effects: cough, dyspnoea, increased upper airway secretion. Patient was hospitalized.

6199368-8 | Depression, Hyperhidrosis, Influenza Like Illness, Thyroid Disorder
on May 11, 2009 Male patient from UNITED STATES , weighting 145.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: depression (What is depression?), hyperhidrosis, influenza like illness, thyroid disorder. Apokyn dosage: 0.3 Ml Prn, [typically About A ^couple ^ Of Times Each Week] Subcutaneous). During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), COMTAN (View Comtan Review and Comtan Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), AZILECT (View Azilect Review and Azilect Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ). Patient was hospitalized.

6198267-5 | Antiphospholipid Syndrome, Dysgeusia, Musculoskeletal Pain, Nausea, Pain In Extremity, Pleural Effusion, Pulmonary Embolism
on May 11, 2009 Male patient from UNITED STATES , 33 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), pneumonia (What is pneumonia?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: antiphospholipid syndrome, dysgeusia, musculoskeletal pain, nausea (What is nausea?), pain in extremity, pleural effusion, pulmonary embolism (What is pulmonary embolism?). Apokyn dosage: (0.3 Ml Prn, [about Once Per Day] Subcutaneous). During the same period patient was treated with ENDOMYCIN ((df)) (View Endomycin Review and Endomycin Label ).

6186565-0 | Visual Impairment
Patient was taking Apokyn (View Usage). Patient had the following side effects: visual impairment on May 01, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 140.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.2 Ml, Subcutaneous. During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), ELDEPRYL (View Eldepryl Review and Eldepryl Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6181987-6 | Contusion, Dysstasia, Fall
Adverse event was reported on Apr 27, 2009 by a Male patient taking Apokyn (View Usage) (Dosage: (0.5 Ml Prn, Once Daily Subcutaneous), (0.5 Ml Prn, Twice Daily Subcutaneous)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 67 years of age, After Apokyn was administered, patient had the following side effects: contusion, dysstasia, fall (What is fall?). Patient was hospitalized.

6125200-4 | Contusion, Fall, Mobility Decreased
on Mar 11, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, fall (What is fall?), mobility decreased. Apokyn dosage: 0.5 Ml Prn, Once Daily, Subcutaneous. Patient was hospitalized.

6104697-X | Blood Pressure Increased, Paraesthesia, Vision Blurred
on Feb 23, 2009 Male patient from UNITED STATES , weighting 242.5 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: blood pressure increased, paraesthesia, vision blurred. Apokyn dosage: 0.2 Ml 1x Subcutaneous). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SINEMET (View Sinemet Review and Sinemet Label ), REQUIP (View Requip Review and Requip Label ).

6083405-5 | Abasia, Hypophagia, Muscle Rigidity, Tremor
Patient was taking Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: abasia, hypophagia, muscle rigidity, tremor on Feb 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 130.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.1 Ml Bid Subcutaneous. During the same period patient was treated with COMTAN (View Comtan Review and Comtan Label ), SINEMET (View Sinemet Review and Sinemet Label ), MIRAPEX (View Mirapex Review and Mirapex Label ).

6078435-3 | Freezing Phenomenon
Adverse event was reported on Feb 02, 2009 by a Male patient taking Apokyn (View Usage) (Dosage: (0.2 Ml, No More Than Three Times Per Day Subcutaneous)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: freezing phenomenon.

6074536-4 | Fall, Pulmonary Oedema
on Feb 02, 2009 Male patient from UNITED STATES , 77 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient had the following side effects: fall (What is fall?), pulmonary oedema. Apokyn dosage: One Dose Subcutaneous.

6071415-3 | Blood Pressure Increased, Hyperhidrosis, Night Sweats, Oedema Peripheral, Thirst
on Jan 29, 2009 Male patient from UNITED STATES , 66 years of age, weighting 178.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: blood pressure increased, hyperhidrosis, night sweats, oedema peripheral, thirst. Apokyn dosage: (0.3 Ml 1x/4 Days Subcutaneous. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), REQUIP (View Requip Review and Requip Label ), MIDODRINE (View Midodrine Review and Midodrine Label ), AZILECT /01759902/ (View Azilect /01759902/ Review and Azilect /01759902/ Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6055276-4 | Asthma, Bronchitis, Chronic Obstructive Pulmonary Disease, Cough
Patient was taking Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, cough on Jan 14, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.1 Ml Qd Subcutaneous. Patient was hospitalized.

6043359-4 | Abasia, Muscle Rigidity, Tremor
Adverse event was reported on Jan 06, 2009 by a Male patient taking Apokyn (View Usage) (Dosage: ().1 Ml Bid Subcutaneous)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: abasia, muscle rigidity, tremor.

6025824-9 | Burning Sensation, Chest Pain, Dyskinesia, Flushing, Hypotension, Nausea, Pallor, Yawning
on Dec 22, 2008 Male patient from UNITED STATES , 64 years of age, weighting 131.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). After Apokyn was administered, patient had the following side effects: burning sensation, chest pain (What is chest pain?), dyskinesia, flushing, hypotension, nausea (What is nausea?), pallor, yawning. Apokyn dosage: 0.2 Ml To 0.3 Ml, Once Daily Subcutaneous.

6024133-1 | Abasia, Gait Disturbance, Movement Disorder, Pain, Pain In Extremity, Somnolence
on Dec 17, 2008 Female patient from UNITED STATES , weighting 225.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Apokyn (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, gait disturbance, movement disorder (What is movement disorder?), pain (What is pain?), pain in extremity, somnolence. Apokyn dosage: 0.2 Ml Qd Subcutaneous. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), MIRAPEX (View Mirapex Review and Mirapex Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), TIGAN (View Tigan Review and Tigan Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6022132-7 | Brachial Plexus Injury, Fall
Patient was taking Apokyn (View Usage). Patient had the following side effects: brachial plexus injury, fall (What is fall?) on Dec 16, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Apokyn dosage: 0.3 Ml, [irregular Frequency], Subcutaneous. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.